Lyndra Therapeutics inks $55 mln Series B

Watertown, Massachusetts-based Lyndra Therapeutics, "which is moving toward making daily pills a thing of the past," has raised $55 million in Series B financing. The investors included Polaris Partners, HOPU Investments, Gilead Sciences, Invus, the Bill & Melinda Gates Foundation and Orient Life.